Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Petar Mas"'
Autor:
Josipa Bukic, Doris Rusic, Petar Mas, Deni Karabatic, Josko Bozic, Ana Seselja Perisin, Dario Leskur, Darko Krnic, Sinisa Tomic, Darko Modun
Publikováno v:
BMC Pharmacology and Toxicology, Vol 20, Iss 1, Pp 1-7 (2019)
Abstract Background Adverse drug reaction (ADR) reporting practices by health care professionals remain poor. Over-the-counter (OTC) drugs are perceived as safe; however, they can also cause ADRs. The objective of this study was to analyze ADR report
Externí odkaz:
https://doaj.org/article/16109b8cce4a40e28ab898a766bf9378
Autor:
Deni Karabatic, Petar Mas, Ana Šešelja Perišin, Dario Leskur, Josko Bozic, Josipa Bukic, Darko Modun, Siniša Tomić, Doris Rusic, Darko Krnić
Publikováno v:
BMC Pharmacology and Toxicology, Vol 20, Iss 1, Pp 1-7 (2019)
BMC Pharmacology & Toxicology
BMC Pharmacology & Toxicology
BackgroundAdverse drug reaction (ADR) reporting practices by health care professionals remain poor. Over-the-counter (OTC) drugs are perceived as safe; however, they can also cause ADRs. The objective of this study was to analyze ADR reporting for OT
Autor:
H. Taavola, Victoria Newbould, Ola Caster, Petar Mas, Philip Michael Tregunno, Ingrid Oosterhuis, Sara Gama, Linda Härmark
Publikováno v:
Drug Safety
Introduction Spontaneous reporting of suspected adverse drug reactions is key for efficient post-marketing safety surveillance. To increase usability and accessibility of reporting tools, the Web-Recognising Adverse Drug Reactions (WEB-RADR) consorti
BACKGROUND: Data on the frequency of pharmacogenetic polymorphisms in the Croatian population are limited. We determined and analyzed frequencies for the most important CYP2C9, CYP2C19, CYP2D6, CYP3A4, and CYP3A5 genetic variants in the Croatian popu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd2fb22c118acae0cce2a3420264de9d
https://www.bib.irb.hr/974036
https://www.bib.irb.hr/974036